177 related articles for article (PubMed ID: 11297585)
1. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas.
Bernier MO; Leenhardt L; Hoang C; Aurengo A; Mary JY; Menegaux F; Enkaoua E; Turpin G; Chiras J; Saillant G; Hejblum G
J Clin Endocrinol Metab; 2001 Apr; 86(4):1568-73. PubMed ID: 11297585
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma.
Orita Y; Sugitani I; Matsuura M; Ushijima M; Tsukahara K; Fujimoto Y; Kawabata K
Surgery; 2010 Mar; 147(3):424-31. PubMed ID: 20176243
[TBL] [Abstract][Full Text] [Related]
3. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
Haq M; Harmer C
Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma.
Schlumberger M; Tubiana M; De Vathaire F; Hill C; Gardet P; Travagli JP; Fragu P; Lumbroso J; Caillou B; Parmentier C
J Clin Endocrinol Metab; 1986 Oct; 63(4):960-7. PubMed ID: 3745409
[TBL] [Abstract][Full Text] [Related]
5. Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables.
Ruegemer JJ; Hay ID; Bergstralh EJ; Ryan JJ; Offord KP; Gorman CA
J Clin Endocrinol Metab; 1988 Sep; 67(3):501-8. PubMed ID: 3410936
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer.
Qiu ZL; Song HJ; Xu YH; Luo QY
J Clin Endocrinol Metab; 2011 Oct; 96(10):3078-86. PubMed ID: 21795449
[TBL] [Abstract][Full Text] [Related]
7. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors.
Lee J; Soh EY
Ann Surg; 2010 Jan; 251(1):114-9. PubMed ID: 19779325
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous osteoplasty combined with radioiodine therapy as a treatment for bone metastasis developing after differentiated thyroid carcinoma.
Song HJ; Wu CG; Xue YL; Xu YH; Qiu ZL; Luo QY
Clin Nucl Med; 2012 Jun; 37(6):e129-33. PubMed ID: 22614210
[TBL] [Abstract][Full Text] [Related]
9. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
Schlumberger M; Challeton C; De Vathaire F; Travagli JP; Gardet P; Lumbroso JD; Francese C; Fontaine F; Ricard M; Parmentier C
J Nucl Med; 1996 Apr; 37(4):598-605. PubMed ID: 8691248
[TBL] [Abstract][Full Text] [Related]
10. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Jarzab B; Handkiewicz-Junak D; Wloch J
Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
[TBL] [Abstract][Full Text] [Related]
11. Recurrent disease in juvenile differentiated thyroid carcinoma: prognostic factors, treatments, and outcomes.
Mihailovic J; Nikoletic K; Srbovan D
J Nucl Med; 2014 May; 55(5):710-7. PubMed ID: 24722527
[TBL] [Abstract][Full Text] [Related]
12. Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients.
Pittas AG; Adler M; Fazzari M; Tickoo S; Rosai J; Larson SM; Robbins RJ
Thyroid; 2000 Mar; 10(3):261-8. PubMed ID: 10779141
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome after bone metastasis (BM) surgery in patients with differentiated thyroid carcinoma (DTC): a retrospective study of 40 cases.
Nakayama R; Horiuchi K; Susa M; Watanabe I; Watanabe K; Tsuji T; Matsumoto M; Toyama Y; Morioka H
Jpn J Clin Oncol; 2014 Oct; 44(10):918-25. PubMed ID: 25104791
[TBL] [Abstract][Full Text] [Related]
14. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors associated with the survival of patients developing loco-regional recurrences of differentiated thyroid carcinomas.
Rouxel A; Hejblum G; Bernier MO; Boëlle PY; Ménégaux F; Mansour G; Hoang C; Aurengo A; Leenhardt L
J Clin Endocrinol Metab; 2004 Nov; 89(11):5362-8. PubMed ID: 15531482
[TBL] [Abstract][Full Text] [Related]
16. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades.
Dinneen SF; Valimaki MJ; Bergstralh EJ; Goellner JR; Gorman CA; Hay ID
J Clin Endocrinol Metab; 1995 Jul; 80(7):2041-5. PubMed ID: 7608252
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
[TBL] [Abstract][Full Text] [Related]
18. Approach to the thyroid cancer patient with extracervical metastases.
Haugen BR; Kane MA
J Clin Endocrinol Metab; 2010 Mar; 95(3):987-93. PubMed ID: 20203334
[TBL] [Abstract][Full Text] [Related]
19. 124I PET Assessment of Response of Bone Metastases to Initial Radioiodine Treatment of Differentiated Thyroid Cancer.
Jentzen W; Verschure F; van Zon A; van de Kolk R; Wierts R; Schmitz J; Bockisch A; Binse I
J Nucl Med; 2016 Oct; 57(10):1499-1504. PubMed ID: 27199362
[TBL] [Abstract][Full Text] [Related]
20. Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience.
Mazziotti G; Formenti AM; Panarotto MB; Arvat E; Chiti A; Cuocolo A; Dottorini ME; Durante C; Agate L; Filetti S; Felicetti F; Filice A; Pace L; Pellegrino T; Rodari M; Salvatori M; Tranfaglia C; Versari A; Viola D; Frara S; Berruti A; Giustina A; Giubbini R
Endocrine; 2018 Jan; 59(1):90-101. PubMed ID: 29110129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
